PT - JOURNAL ARTICLE AU - Viswanath, Narayanan C. TI - Analysis of the Second COVID-19 Wave in India and the United Kingdom Using a Birth-Death Model AID - 10.1101/2021.06.16.21259009 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.16.21259009 4099 - http://medrxiv.org/content/early/2021/06/18/2021.06.16.21259009.short 4100 - http://medrxiv.org/content/early/2021/06/18/2021.06.16.21259009.full AB - Several countries have witnessed multiple waves of the COVID-19 pandemic between 2020 and 21. The method in [8] is applied here to analyze the COVID-19 waves in India and the UK. For this, a birth-death model is fitted to the active and total cases data for 30 days periods called windows starting from 16th March 2020 up to 10th May 2021. Peculiarities of the parameters suggested a classification of the above windows into three categories: (i) whose fitted parameters predicted a rise in the number of active cases before a fall to zero, (ii) which predicted a decrease, without rising, in the active cases to zero and (iii) which predicted an increase in the active cases until the entire susceptible population gets infected. It follows that some of the type (iii) windows are of the same or lesser concern when compared to some type (i) windows. Further analysis of the type (iii) windows leads to the identification of those which could be indicators of the start of a new wave of the pandemic. The study thus proposes a method for using the present data for identifying pandemic waves in the near future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding is received for the present studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Government Engineering College, ThrissurAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available from https://www.worldometers.info/coronavirus/country/india https://www.worldometers.info/coronavirus/country/uk https://www.worldometers.info/coronavirus/country/india https://www.worldometers.info/coronavirus/country/uk